학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 118건 | 목록 1~20
Academic Journal
CPT Pharmacometrics Syst Pharmacol
CPT: Pharmacometrics & Systems Pharmacology, Vol 14, Iss 1, Pp 164-178 (2025)
Izat, N, Bolleddula, J, Carione, P, Huertas Valentin, L, Jones, R S, Kulkarni, P, Moss, D, Peterkin, V C, Tian, D-D, Treyer, A, Venkatakrishnan, K, Zientek, M A, Barber, J, Houston, J, Galetin, A & Scotcher, D 2025, 'Establishing a physiologically-based pharmacokinetic framework for aldehyde oxidase and dual aldehyde oxidase-CYP substrates', CPT: Pharmacometrics and Systems Pharmacology, vol. 14, no. 1, pp. 164-178. https://doi.org/10.1002/psp4.13255
Academic Journal
Izat, N, Bolleddula, J, Abbasi, A, Cheruzel, L, Jones, R, Moss, D, Ortega-Muro, F, Parmentier, Y, Peterkin, V C, Tian, D-D, Venkatakrishnan, K, Zientek, M, Barber, J, Houston, J, Galetin, A & Scotcher, D 2023, 'Challenges and opportunities for in vitro-in vivo extrapolation of aldehyde oxidase-mediated clearance: Towards a roadmap for quantitative translation', Drug Metabolism and Disposition.
Academic Journal
Reddy MB; Clinical Pharmacology, Oncology, Pfizer Inc., Boulder, Colorado, USA.; Cabalu TD; DMPK, Pharmacokinetics, Dynamics, Metabolism, and Bioanalytics, Merck & Co., Inc., Rahway, New Jersey, USA.; de Zwart L; DMPK, Janssen Pharmaceutica NV, A Johnson & Johnson Company, Beerse, Belgium.; Ramsden D; DMPK, Research and Early Development, Oncology R&D, AstraZeneca, Boston, Massachusetts, USA.; Dowty ME; Pharmacokinetics Dynamics and Metabolism, Pfizer Inc, Cambridge, Massachusetts, USA.; Taskar KS; DMPK, Pre-Clinical Sciences, Research Technologies, GSK, Stevenage, UK.; Badée J; PK Sciences, Biomedical Research, Novartis, Basel, Switzerland.; Bolleddula J; Quantitative Pharmacology, EMD Serono Research & Development Institute, Inc., Billerica, Massachusetts, USA.; Boulu L; Modeling and Simulation, Translational Medicine and Early Development, Sanofi, Montpellier, France.; Fu Q; Modeling and Simulation, Vertex Pharmaceuticals, Boston, Massachusetts, USA.; Kotsuma M; Quantitative Clinical Pharmacology, Daiichi Sankyo Co., Ltd., Tokyo, Japan.; Leblanc AF; Quantitative, Translational & ADME Sciences, Development Science, AbbVie, North Chicago, Illinois, USA.; Lewis G; DMPK, Pre-Clinical Sciences, Research Technologies, GSK, Stevenage, UK.; Liang G; DMPK, Vertex Pharmaceuticals, Boston, Massachusetts, USA.; Parrott N; Pharmaceutical Sciences, Roche Pharma Research & Early Development, Roche Innovation Center Basel, Basel, Switzerland.; Pilla Reddy V; Global PKPD/Pharmacometrics, Eli Lilly and Company, Bracknell, UK and Indianapolis, Indiana, USA.; Prakash C; DMPK and Clinical Pharmacology, Agios, Cambridge, Massachusetts, USA.; Shah K; Quantitative Clinical Pharmacology, Takeda Pharmaceuticals International Inc., Cambridge, Massachusetts, USA.; Umehara K; Roche Pharmaceutical Research and Early Development, Roche Innovation Center, F. Hoffmann-La Roche Ltd., Basel, Switzerland.; Mukherjee D; Quantitative Clinical Pharmacology, Daiichi-Sankyo Inc., Basking Ridge, New Jersey, USA.; Rehmel J; Global PKPD/Pharmacometrics, Eli Lilly and Company, Bracknell, UK and Indianapolis, Indiana, USA.; Hariparsad N; DMPK, Research and Early Development, Oncology R&D, AstraZeneca, Boston, Massachusetts, USA.
Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-6535 (Electronic) Linking ISSN: 00099236 NLM ISO Abbreviation: Clin Pharmacol Ther Subsets: MEDLINE
Academic Journal
Bolleddula J; EMD Serono, Billerica, MA, USA.; Scheible H; The Healthcare Business of Merck KGaA, Darmstadt, Germany.; Huber F; The Healthcare Business of Merck KGaA, Darmstadt, Germany.; Seithel-Keuth A; The Healthcare Business of Merck KGaA, Darmstadt, Germany.; Schieferstein H; The Healthcare Business of Merck KGaA, Darmstadt, Germany.; Vagge DS; Merck Specialities Pvt. Ltd., an affiliate of Merck KGaA, Darmstadt, Germany, Bangalore, India.; Mammasse N; Cytel, Paris, France.; Jaks E; The Healthcare Business of Merck KGaA, Darmstadt, Germany.; Ferrer J; The Healthcare Business of Merck KGaA, Darmstadt, Germany.; Moulin C; The Healthcare Business of Merck KGaA, Darmstadt, Germany.; Dong J; EMD Serono, Billerica, MA, USA.; Venkatakrishnan K; EMD Serono, Billerica, MA, USA.; Papai Z; Medical Centre, Hungarian Defence Forces, Budapest, Hungary.
Publisher: Wiley Country of Publication: United States NLM ID: 101572899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2160-7648 (Electronic) Linking ISSN: 2160763X NLM ISO Abbreviation: Clin Pharmacol Drug Dev Subsets: MEDLINE
Academic Journal
Lu H; Merck Serono (Beijing) Pharmaceutical R&D Co., Ltd., Beijing, China.; Klopp-Schulze L; Merck Healthcare KGaA, Darmstadt, Germany.; Mukker JK; EMD Serono Research and Development Institute Inc., Billerica, Massachusetts, USA.; Li D; Merck Serono (Beijing) Pharmaceutical R&D Co., Ltd., Beijing, China.; Kuroki Y; Japan Merck Biopharma Co., Ltd., Tokyo, Japan.; Bolleddula J; EMD Serono Research and Development Institute Inc., Billerica, Massachusetts, USA.; Terranova N; Ares Trading S.A. (an Affiliate of Merck KGaA, Darmstadt, Germany), Lausanne, Switzerland.; Goteti K; EMD Serono Research and Development Institute Inc., Billerica, Massachusetts, USA.; Gao W; EMD Serono Research and Development Institute Inc., Billerica, Massachusetts, USA.; Strotmann R; Merck Healthcare KGaA, Darmstadt, Germany.; Dong J; EMD Serono Research and Development Institute Inc., Billerica, Massachusetts, USA.; Venkatakrishnan K; EMD Serono Research and Development Institute Inc., Billerica, Massachusetts, USA.
Publisher: WileyBlackwell Pub Country of Publication: United States NLM ID: 101474067 Publication Model: Print Cited Medium: Internet ISSN: 1752-8062 (Electronic) Linking ISSN: 17528054 NLM ISO Abbreviation: Clin Transl Sci Subsets: MEDLINE
Academic Journal
Scheible H; NCE DMPK Merck Healthcare KGaA, Darmstadt, Germany.; Schieferstein H; NCE DMPK Merck Healthcare KGaA, Darmstadt, Germany.; Schmidt R; EMD Serono Research & Development Institute, Inc, Billerica, MA, USA, an affiliate of Merck KGaA, Darmstadt, Germany.; Pusecker K; NCE DMPK Merck Healthcare KGaA, Darmstadt, Germany.; Gradhand U; NCE DMPK Merck Healthcare KGaA, Darmstadt, Germany.; Gopalakrishnan S; Quantitative Pharmacology Merck Healthcare KGaA, Darmstadt, Germany.; Iqbal K; Quantitative Pharmacology Merck Healthcare KGaA, Darmstadt, Germany.; Dong J; EMD Serono Research & Development Institute, Inc, Billerica, MA, USA, an affiliate of Merck KGaA, Darmstadt, Germany.; Jones R; EMD Serono Research & Development Institute, Inc, Billerica, MA, USA, an affiliate of Merck KGaA, Darmstadt, Germany.; Meli C; Merck Ltd, Piedmont, Italy, an affiliate of Merck KGaA, Darmstadt, Germany.; Bolleddula J; EMD Serono Research & Development Institute, Inc, Billerica, MA, USA, an affiliate of Merck KGaA, Darmstadt, Germany.; Dyroff M; EMD Serono Research & Development Institute, Inc, Billerica, MA, USA, an affiliate of Merck KGaA, Darmstadt, Germany.; Georgi K; NCE DMPK Merck Healthcare KGaA, Darmstadt, Germany.
Publisher: Informa Healthcare Country of Publication: England NLM ID: 1306665 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1366-5928 (Electronic) Linking ISSN: 00498254 NLM ISO Abbreviation: Xenobiotica Subsets: MEDLINE
Academic Journal
Mukker JK; EMD Serono, Billerica, Massachusetts, USA.; Diderichsen PM; Certara USA, Inc., Radnor, Pennsylvania, USA.; Hellmann F; Certara USA, Inc., Radnor, Pennsylvania, USA.; Yap TA; Department of Investigational Cancer Therapeutics, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Plummer R; Newcastle University and Northern Centre for Cancer Care, Newcastle Hospitals NHS Trust, Newcastle Upon Tyne, UK.; Tolcher AW; Clinical Research, New Experimental Therapeutics (NEXT), San Antonio, Texas, USA.; de Bono JS; Division of Clinical Studies, Royal Marsden Hospital, Sutton, UK.; Gounaris I; Merck Serono Ltd., Feltham, UK, an affiliate of Merck KGaA, Darmstadt, Germany.; Szucs Z; Merck Serono Ltd., Feltham, UK, an affiliate of Merck KGaA, Darmstadt, Germany.; Zimmermann A; The Healthcare Business of Merck KGaA, Darmstadt, Germany.; Kareva I; EMD Serono, Billerica, Massachusetts, USA.; Bolleddula J; EMD Serono, Billerica, Massachusetts, USA.; Seithel-Keuth A; The Healthcare Business of Merck KGaA, Darmstadt, Germany.; Locatelli G; The Healthcare Business of Merck KGaA, Darmstadt, Germany.; Enderlin M; The Healthcare Business of Merck KGaA, Darmstadt, Germany.; Hicking C; The Healthcare Business of Merck KGaA, Darmstadt, Germany.; Zutshi A; EMD Serono, Billerica, Massachusetts, USA.; Gao W; EMD Serono, Billerica, Massachusetts, USA.; Strotmann R; The Healthcare Business of Merck KGaA, Darmstadt, Germany.; Benincosa L; EMD Serono, Billerica, Massachusetts, USA.; Venkatakrishnan K; EMD Serono, Billerica, Massachusetts, USA.
Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-6535 (Electronic) Linking ISSN: 00099236 NLM ISO Abbreviation: Clin Pharmacol Ther Subsets: MEDLINE
Academic Journal
Villette CC; Physiomics PLC, Abingdon, UK.; Dupuy N; Physiomics PLC, Abingdon, UK.; Brightman FA; Physiomics PLC, Abingdon, UK.; Zimmermann A; Merck Healthcare KGaA, Darmstadt, Germany.; Lignet F; Merck Healthcare KGaA, Darmstadt, Germany.; Zenke FT; EMD Serono Research & Development Institute, Inc., Billerica, MA, USA.; Terranova N; Quantitative Pharmacology, Ares Trading S.A. (An Affiliate of Merck KGaA, Darmstadt, Germany), Lausanne, Switzerland.; Bolleddula J; EMD Serono Research & Development Institute, Inc., Billerica, MA, USA.; El Bawab S; Merck Healthcare KGaA, Darmstadt, Germany.; Chassagnole C; Physiomics PLC, Abingdon, UK. cchassagnole@physiomics.co.uk.
Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE
Academic Journal
Bakka AG; Department of Pharmacology, RVM Institute of Medical Sciences and Research Center, Laxmakkapally, IND.; Patil SS; Department of Pharmacology, RVM Institute of Medical Sciences and Research Center, Laxmakkapally, IND.; Rachakonda B; Department of Pharmacology, RVM Institute of Medical Sciences and Research Center, Laxmakkapally, IND.; Patil A; Department of Internal Medicine, Shri Bhausaheb Hire Government Medical College, Dhule, IND.; Bolleddula J; Department of Pharmacology, RVM Institute of Medical Sciences and Research Center, Laxmakkapally, IND.; Nandyala PSKR; Department of Medicine, RVM Institute of Medical Sciences and Research Center, Laxmakkapally, IND.; Singamaneni R; Department of Pharmacology, RVM Institute of Medical Sciences and Research Center, Laxmakkapally, IND.; Sade N; Department of Internal Medicine, Apollo Institute of Medical Sciences and Research, Hyderabad, IND.; Patnaik PK; Department of Pharmacology, RVM Institute of Medical Sciences and Research Center, Laxmakkapally, IND.
Publisher: Cureus, Inc Country of Publication: United States NLM ID: 101596737 Publication Model: eCollection Cited Medium: Print ISSN: 2168-8184 (Print) Linking ISSN: 21688184 NLM ISO Abbreviation: Cureus Subsets: PubMed not MEDLINE
Academic Journal
Hariparsad N; DMPK, Research and Early Development, Oncology R&D, AstraZeneca, Boston, Massachusetts, USA.; Ramsden D; Takeda Development Center Americas, Inc., Cambridge, Massachusetts, USA.; Taskar K; Drug Metabolism and Pharmacokinetics, IVIVT, GlaxoSmithKline, Stevenage, UK.; Badée J; PK Sciences, Novartis Institutes for Biomedical Research, Basel, Switzerland.; Venkatakrishnan K; EMD Serono Research & Development Institute, Inc, Billerica, Massachusetts, USA.; Merck KGaA, Darmstadt, Germany.; Reddy MB; Department of Clinical Pharmacology, Oncology, Pfizer, Boulder, Colorado, USA.; Cabalu T; Merck & Co., Inc., Kenilworth, New Jersey, USA.; Mukherjee D; Clinical Pharmacology & Pharmacometrics, AbbVie, Inc., North Chicago, Illinois, USA.; Rehmel J; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, USA.; Bolleddula J; EMD Serono Research & Development Institute, Inc, Billerica, Massachusetts, USA.; Merck KGaA, Darmstadt, Germany.; Emami Riedmaier A; Bristol Meyers Squibb, Princeton, New Jersey, USA.; Prakash C; Agios Pharmaceuticals, Cambridge, Massachusetts, USA.; Chanteux H; UCB Biopharma, QP-DMPK, Brussels, Belgium.; Mao J; Department of Drug Metabolism and Pharmacokinetics, Genentech, A Member of the Roche Group, South San Francisco, California, USA.; Umehara K; Pharmaceutical Sciences, Roche Pharma Research & Early Development, Roche Innovation Center Basel, Basel, Switzerland.; Shah K; Drug Metabolism and Pharmacokinetics, Vertex Pharmaceuticals Incorporated, Boston, Massachusetts, USA.; De Zwart L; DMPK, Janssen Research and Development, Beerse, Belgium.; Dowty M; Department of Pharmacokinetics, Dynamic, and Metabolism, Pfizer, Cambridge, Massachusetts, USA.; Kotsuma M; Quantitative Clinical Pharmacology, Daiichi-Sankyo, Inc., New Jersey, USA.; Li M; Pharmacokinetics, Dynamics and Metabolism, Sanofi, Bridgewater, New Jersey, USA.; Pilla Reddy V; Clinical Pharmacology and Pharmacometrics, Biopharmaceuticals R&D, AstraZeneca, Cambridge, UK.; McGinnity DF; DMPK, Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UK.; Parrott N; Pharmaceutical Sciences, Roche Pharma Research & Early Development, Roche Innovation Center Basel, Basel, Switzerland.
Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-6535 (Electronic) Linking ISSN: 00099236 NLM ISO Abbreviation: Clin Pharmacol Ther Subsets: MEDLINE
Academic Journal
Bolleddula J; Quantitative Pharmacology, EMD Serono Research & Development Institute, Inc., Billerica, Massachusetts, USA.; Gopalakrishnan S; Merck KGaA, Darmstadt, Germany.; Hu P; Quantitative Pharmacology, EMD Serono Research & Development Institute, Inc., Billerica, Massachusetts, USA.; Dong J; Quantitative Pharmacology, EMD Serono Research & Development Institute, Inc., Billerica, Massachusetts, USA.; Venkatakrishnan K; Quantitative Pharmacology, EMD Serono Research & Development Institute, Inc., Billerica, Massachusetts, USA.
Publisher: WileyBlackwell Pub Country of Publication: United States NLM ID: 101474067 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1752-8062 (Electronic) Linking ISSN: 17528054 NLM ISO Abbreviation: Clin Transl Sci Subsets: MEDLINE
Academic Journal
Burris HA; Sarah Cannon Research Institute, Nashville, TN, USA. howard.burris@scri.com.; Berlin J; Division of Hematology/Oncology, Vanderbilt-Ingram Cancer Center, Nashville, TN, USA.; Arkenau T; Drug Development, Ellipses Pharma, London, UK.; Cote GM; Division of Hematology and Oncology, Mass General Cancer Center, Boston, MA, USA.; Lolkema MP; Department of Medical Oncology, Erasmus MC Cancer Institute, Utrecht, Netherlands.; Amgen Inc., Thousand Oaks, CA, USA.; Ferrer-Playan J; Global Clinical Development, Ares Trading SA, an affiliate of Merck KGaA, Eysins, Switzerland.; Kalapur A; Global Patient Safety Oncology, Merck Healthcare KGaA, Darmstadt, Germany.; Bolleddula J; Quantitative Pharmacology, EMD Serono Research & Development Institute, Inc., an affiliate of Merck KGaA, Billerica, MA, USA.; Locatelli G; Clinical Biomarkers, Merck Healthcare KGaA, Darmstadt, Germany.; Goddemeier T; Biostatistics, Merck Healthcare KGaA, Darmstadt, Germany.; Gounaris I; Global Clinical Development, Merck Serono Ltd., an affiliate of Merck KGaA, Feltham, UK.; de Bono J; Division of Clinical Studies, Institute of Cancer Research, London, UK.; Royal Marsden, Hospital, London, UK.
Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE
Academic Journal
Wang D; EMD Serono Research & Development Institute, Inc., Billerica, MA, USA, an affiliate of Merck KGaA USA.; Bolleddula J; EMD Serono Research & Development Institute, Inc., Billerica, MA, USA, an affiliate of Merck KGaA USA.; Coenen-Stass A; Merck Healthcare KGaA, Darmstadt, Germany.; Grombacher T; Merck Healthcare KGaA, Darmstadt, Germany.; Dong JQ; EMD Serono Research & Development Institute, Inc., Billerica, MA, USA, an affiliate of Merck KGaA USA.; Scheuenpflug J; Merck Healthcare KGaA, Darmstadt, Germany.; Locatelli G; Merck Healthcare KGaA, Darmstadt, Germany.; Feng Z; EMD Serono Research & Development Institute, Inc., Billerica, MA, USA, an affiliate of Merck KGaA USA.
Publisher: Taylor & Francis Country of Publication: England NLM ID: 100897350 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8042 (Electronic) Linking ISSN: 14622416 NLM ISO Abbreviation: Pharmacogenomics Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Bolleddula, J.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어